HOME
HK STOCK
ALL
Announcement
IPOs
Research
Market
Company
CHINA STOCK
ALL
Announcement
IPOs
Research
Market
Company
US STOCK
ALL
Financial Report
New Share
Market
Research
Company
RECOMMENDATIONS
ALL
World News
Hong Kong & MaCao
China News
General News
HK STOCK
ALL
Announcement
IPOs
Research
Market
Company
CHINA STOCK
ALL
Announcement
IPOs
Research
Market
Company
US STOCK
ALL
Financial Report
New Share
Market
Research
Company
RECOMMENDATIONS
ALL
World News
Hong Kong & MaCao
China News
General News
HOME
HK STOCK
ALL
Announcement
IPOs
Research
Market
Company
CHINA STOCK
ALL
Announcement
IPOs
Research
Market
Company
US STOCK
ALL
Financial Report
New Share
Market
Research
Company
RECOMMENDATIONS
ALL
World News
Hong Kong & MaCao
China News
General News
Search for topics & keywords
Search
ZERO2IPO (01945) repurchased 2800 shares on January 9th.
09/01/2025
GMT Eight
ZERO2IPO (01945) announced on January 9, 2025, it will repurchase 2800 shares at a cost of 3544 Hong Kong dollars.
Zhejiang Hisun Pharmaceutical (600267.SH): Evomoside tablets obtained drug registration certificate.
Asia Cuanon Technology (603378.SH) controlling shareholder and actual controller collectively reduce their holdings by 1.07%.
RECOMMEND
Song Xuetao: What incremental signals were released at the press conference of the five ministries?
16 min ago
Morgan Stanley: Key points for visiting the Chinese humanoid Siasun Robot & Automation industry
28 min ago
National Bureau of Statistics interpretation: The current moderate rebound in prices has not changed.
39 min ago
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.
Contact: contact@gmteight.com